I think it does get better than the status quo.
Commercialisation, actual profitable sales, capital gains in the share price and shareholder dividends are all actually better than an expedited FDA approval to do some experimental work.
- Forums
- ASX - By Stock
- IBX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-73
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.425M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.6¢ | $27.63K | 750.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 63865 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 63865 | 0.037 |
2 | 31142 | 0.035 |
1 | 20000 | 0.034 |
3 | 98750 | 0.033 |
1 | 92000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 25000 | 1 |
0.046 | 90637 | 1 |
0.047 | 14800 | 1 |
0.048 | 13016 | 2 |
0.050 | 105885 | 2 |
Last trade - 13.05pm 04/10/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |